Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VIETNarms HCV treatment strategies trial in Vietnam
ISRCTN61522291Phase 3Completed
- Sponsor
- University of Oxford
- Start
- Dec 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of sofosbuvir, daclatasvir, velpatasvir, ribavirin and pegylated interferon alpha in hepatitis C virus infection (4 arms), sponsored by University of Oxford. Started Dec 2019; status: completed.
02
Drugs
sofosbuvirdaclatasvirvelpatasvirribavirinpegylated interferon alpha
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on ISRCTN61522291.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN61522291.